Skip to main content
icon-search-14x14

Adam B. Cohen

(he/him/his)

  • Partner | M&A and Private Equity

New York

T: +1.212.859.8724

Headshot of Adam B. Cohen

Public and private companies across a range of industries turn to Adam Cohen for representation in cross-border and domestic M&A transactions.

Adam's practice focuses on mergers and stock, asset acquisitions and divestitures, majority and minority investments, co-investment transactions, and corporate restructurings. Boards of directors and management teams also seek Adam’s advice on corporate governance issues.

Since 2017, Adam has appeared as a featured panelist regarding M&A transaction sale processes and acquisition agreements at Practising Law Institute’s annual “Acquiring or Selling the Privately Held Company” program in San Francisco.

  • Catalent in numerous engagements including its $1.2 billion acquisition of Paragon Bioservices, its acquisition of MaSTherCell Global, and its $1billion agreement to acquire Bettera Holdings.
  • Becton, Dickinson and Company in multiple transactions, including its acquisition of Tepha, Inc.
  • AEA Investors LP in numerous acquisitions and divestiture...

Public and private companies across a range of industries turn to Adam Cohen for representation in cross-border and domestic M&A transactions.

Adam's practice focuses on mergers and stock, asset acquisitions and divestitures, majority and minority investments, co-investment transactions, and corporate restructurings. Boards of directors and management teams also seek Adam’s advice on corporate governance issues.

Since 2017, Adam has appeared as a featured panelist regarding M&A transaction sale processes and acquisition agreements at Practising Law Institute’s annual “Acquiring or Selling the Privately Held Company” program in San Francisco.

  • Catalent in numerous engagements including its $1.2 billion acquisition of Paragon Bioservices, its acquisition of MaSTherCell Global, and its $1billion agreement to acquire Bettera Holdings.
  • Becton, Dickinson and Company in multiple transactions, including its acquisition of Tepha, Inc.
  • AEA Investors LP in numerous acquisitions and divestitures, including its $3b sale of 1-800 Contacts, Inc.
  • Onex in multiple transactions, including its sale of Jack's Family Restaurants.
  • Humana Inc. in a $5.7 billion deal with TPG Capital and Welsh, Carson, Anderson & Stowe to acquire control of Kindred at Home.
  • CVS Health in its sale of Coventry Workers' Compensation Services to Mitchell | Genex
  • Advanced Integration Technology in its acquisition of Nova Tech Engineering business of Teal Sales and its acquisition of the North American aerospace business of KUKA Systems.
  • Koch Equity Development in its preferred equity investment in connection with the $2.4 billion merger of Air Medical Group Holdings, a KKR portfolio company, with American Medical Response.

News and recognition

News releases |

Fried Frank Elects 12 Partners and Promotes 11 Special Counsel⟶

News releases |

Fried Frank Elects Four Partners and Promotes Four Special Counsel⟶

Insights and analysis

Chancery Reaffirms Very High Bar for Successful Challenge of Even “Terrible” Business Decisions by an Independent Board—Coral Springs v. Dorsey⟶

M&A/PE Briefing |

Non-Majority Stockholder’s Ability to Control a Transaction Did Not Render Him a Controller As He Did Not Try to Control—Oracle⟶

Articles |

Chancery Rejects Dismissal of Caremark Claims Against Walmart’s Officers and Directors⟶

M&A/PE Briefing |

Chancery Court Issues Important Decision Relating to Buyer Indemnification Rights and Seller Participation Rights in Connection with Post-Closing Governmental Investigations—Anthem⟶

M&A/PE Quarterly Newsletter, Spring 2023⟶

M&A/PE Briefing |

Court of Chancery Clarifies that Sophisticated Stockholders of a Delaware Corporation Can Waive Fiduciary Duties Under Certain Circumstances—Fugue⟶

M&A/PE Briefing |

Chancery Ruling Highlights Important Role of Special Litigation Committees in Maintaining Board Control Over Derivative Litigation—Baker Hughes⟶

M&A/PE Briefing |

Chancery Rejects Dismissal of Caremark Claims Against Walmart’s Officers and Directors for the Company’s Role in the Opioid Epidemic⟶

M&A/PE Briefing |

Chancery Expands Caremark Parameters—but Dismisses Claims Against McDonald’s Directors Because They Took Action to Address Sexual Harassment Once They Learned of It⟶

M&A/PE Briefing |

Chancery Grants Judicial Validation of SPACs’ Potentially Defective Charter Amendments and Share Issuances Effected Without a Separate Vote of Class A Common Shares—Lordstown⟶
See more + View more⟶

Events

Speaking engagements |

Acquiring or Selling the Privately Held Company 2023⟶

Speaking engagements |

PLI's "Acquiring or Selling the Privately Held Company"⟶

Webinars |

Acquiring or Selling the Privately Held Company⟶

Speaking engagements |

Acquiring or Selling the Privately Held Company 2019⟶

Speaking engagements |

Mock Negotiation and Analysis of Form of Acquisition Agreement⟶
See more +
Back to top ↑

Email Disclaimer

I have read and understood the terms of use of this web site which appear below, and specifically agree to those terms, on behalf of myself and anyone else on whose behalf I am contacting anyone at Fried Frank using this site or in any way connected with this site:

The information and materials offered on this site are for general informational purposes only, do not constitute and should not be considered to be legal advice, and are presented without any representation or warranty whatsoever, including as to the accuracy or completeness of the information. No one should, or is entitled to, rely in any manner on any of the information at this site. Parties seeking advice should consult with legal counsel familiar with their particular circumstances.

Prior results do not guarantee a similar outcome.

No attorney-client relationship is created by our transmission of information from this site or by any communication by others to us (or to any of our attorneys, staff, employees, agents or representatives) through or in any way connected with this site. Users communicating with us (or to any of our attorneys, staff, employees, agents or representatives) are cautioned that we do not undertake to hold such communications or their contents in confidence and, accordingly, that they should be careful not to communicate confidential information to us. Users are further cautioned that we may represent a party directly adverse to them either now or at a later date, and that we remain free to do so notwithstanding any information which is communicated to us by the user or any other person or any solicitation of our services by the user or any other person. An attorney-client relationship between Fried Frank and users of this site or anyone else is created only by a written engagement letter signed by a partner of Fried Frank, and no course of communication shall constitute an undertaking to receive confidential information in connection with a discussion of possible future representation unless such undertaking is contained in a written letter agreement signed by a partner of Fried Frank specifying the conditions of such receipt and countersigned by a person with authority to bind the prospective client.

Links to information on sites other than those operated by, or on behalf of, Fried Frank are for your convenience only and are not an endorsement or recommendation of those sites. Fried Frank does not take any responsibility for information at these sites, nor makes any representation or warranty with respect to these sites or their information.

By clicking "Accept", I specifically agree to these terms, on behalf of myself and anyone else on whose behalf I am contacting anyone at Fried Frank.